Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2004-03-01 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CENON (33150), Gironde
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES QUATRE PAVILLONS : revenue, balance sheet and financial ratios
PHARMACIE DES QUATRE PAVILLONS is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CENON (33150),
this company of category PME
shows in 2016 a revenue of 2.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES QUATRE PAVILLONS (SIREN 452710528)
Indicator
2024
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
2 334 552 €
Net income
259 569 €
100 178 €
248 680 €
54 328 €
63 579 €
36 315 €
89 195 €
103 879 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
191 623 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
4.4%
Revenue and income statement
In 2024, PHARMACIE DES QUATRE PAVILLONS generates positive net income of 260 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 104 k€ -> 260 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
259 569 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 51%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
51.164%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
47.408%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES QUATRE PAVILLONS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Debt ratio
107.268
132.7
203.961
162.396
239.113
101.085
47.384
51.164
Financial autonomy
33.236
29.887
22.055
26.491
20.761
31.008
49.252
47.408
Repayment capacity
0.048
None
None
None
None
None
None
None
Cash flow / Revenue
348.393%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
51.162024
2021
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good-8 pts over 3 years
In 2024, the debt ratio of PHARMACIE DES QUATRE PAVI... (51.16) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
47.41%2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+15 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DES QUATRE PAVI... (47.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 226.67. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
226.67
Liquidity indicators evolution PHARMACIE DES QUATRE PAVILLONS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Liquidity ratio
119.096
183.251
179.134
178.234
208.266
173.05
252.372
226.67
Interest coverage
3.037
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
226.672024
2021
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+23 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DES QUATRE PAVI... (226.67) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 111 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 600 days. Excellent situation: suppliers finance 489 days of the operating cycle (retail model).
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
111 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
600 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES QUATRE PAVILLONS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Operating WCR
337 810 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
37
0
0
0
0
0
0
0
Customer payment term (days)
16
0
0
0
0
0
152
111
Supplier payment term (days)
56
0
0
0
0
0
635
600
Positioning of PHARMACIE DES QUATRE PAVILLONS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DES QUATRE PAVILLONS is estimated at
3 623 775 €
(range 2 523 539€ - 5 421 374€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2523k€3623k€5421k€
3 623 775 €Range: 2 523 539€ - 5 421 374€
NAF 5 année 2024
Valuation method used
Net Income Multiple
259 569 €
×
14.0x
=3 623 775 €
Range: 2 523 540€ - 5 421 375€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES QUATRE PAVILLONS with other companies in the same sector:
Frequently asked questions about PHARMACIE DES QUATRE PAVILLONS
What is the revenue of PHARMACIE DES QUATRE PAVILLONS ?
The revenue of PHARMACIE DES QUATRE PAVILLONS in 2016 is 2.3 M€.
Is PHARMACIE DES QUATRE PAVILLONS profitable?
Yes, PHARMACIE DES QUATRE PAVILLONS generated a net profit of 260 k€ in 2024.
Where is the headquarters of PHARMACIE DES QUATRE PAVILLONS ?
The headquarters of PHARMACIE DES QUATRE PAVILLONS is located in CENON (33150), in the department Gironde.
Where to find the tax return of PHARMACIE DES QUATRE PAVILLONS ?
The tax return of PHARMACIE DES QUATRE PAVILLONS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES QUATRE PAVILLONS operate?
PHARMACIE DES QUATRE PAVILLONS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart